trending Market Intelligence /marketintelligence/en/news-insights/trending/4b1u8bp3qajshaagkmwjla2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

SI-BONE files for $90M US IPO to fund surgical implant system

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

SI-BONE files for $90M US IPO to fund surgical implant system

SI-BONE Inc. filed for an IPO to raise about $90 million, which will be used to fund the ongoing commercialization of the company's iFuse implant system.

The Santa Clara, Calif.-based medical device company will offer 6,000,000 common shares at a price of between $13 and $15, according to an Oct. 5 regulatory filing. The company will apply to list its shares on the Nasdaq Global Market under the ticker SIBN.

Underwriters will have a 30-day option to purchase up to an additional 900,000 shares. Assuming full exercise of the overallotment option at the top end of the given price range, the company could raise $103.5 million from the flotation. Existing shareholders have expressed interest for up to $32 million in common shares in the IPO.

SI-BONE intends to use proceeds from the share sale primarily to support ongoing commercialization of the iFuse implant system, a minimally invasive surgical option for patients with sacroiliac joint dysfunction, a source of pain in the low back and legs caused by abnormal motion in the sacroiliac joint.

Morgan Stanley & Co. LLC, Merrill Lynch Pierce Fenner & Smith Inc., Canaccord Genuity LLC and JMP Securities LLC serve as underwriters on the transaction.